Lv5
820 积分 2022-06-19 加入
Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials
2个月前
已完结
Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials
2个月前
已完结
Development of an inhaled anti-TSLP therapy for asthma
2个月前
已完结
Comparison of CD30L and OX40L Reveals CD30L as a Promising Therapeutic Target in Atopic Dermatitis
3个月前
已完结
CD70 is Consistently Expressed in Primary and Metastatic Clear Cell Renal Cell Carcinoma
4个月前
已完结
A Monoclonal Antibody to PACAP for Migraine Prevention
4个月前
已完结
Reverse signaling via CD30 ligand
5个月前
已完结
Reverse signaling via CD30 ligand
5个月前
已完结
Increased Expression of IRE1α Associates with the Resistant Mechanism of Osimertinib (AZD9291)-resistant non-small Cell Lung Cancer HCC827/OSIR Cells
11个月前
已完结
EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
11个月前
已关闭
皖公网安备34019202002308
